HC Wainwright Predicts Higher Earnings for Vir Biotechnology
Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) – Investment analysts at HC Wainwright lifted their Q2 2025 earnings estimates for shares of Vir Biotechnology in a research note issued to investors on Tuesday, May 20th. HC Wainwright analyst P. Trucchio now anticipates that the company will earn ($0.54) per share for the quarter, up from […]
Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) – Investment analysts at HC Wainwright lifted their Q2 2025 earnings estimates for shares of Vir Biotechnology in a research note issued to investors on Tuesday, May 20th. HC Wainwright analyst P. Trucchio now anticipates that the company will earn ($0.54) per share for the quarter, up from […]
